Confirmation in future studies of an association between two APOL1 risk alleles with HIV viremia and CKD would have significant therapeutic implications regarding APOL1 inhibition in patients with two risk alleles, who do not reside in Trypanosoma endemic areas. Here, APOL1 is linked to chronic kidney disease.